This content is restricted to site members. If you are an existing user, please log in. New users may register below.
Europe approves novel Australian drug developed for rare sun disease
The first new pharmaceutical drug invented and developed for an untreated disorder by any Australian company has received regulatory approval from the European Medicines Agency (EMA). SCENESSE® (afamelanotide 16mg) treats